ONWRF (Onward Medical NV) ROE % Adjusted to Book Value: -20.24% (As of Dec. 2025)


ONWRF Onward Medical NV ONWRF
37 GF Score
Price $2.96
GF Value $154.42
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV ROE % Adjusted to Book Value?

Onward Medical NV ONWRF 37 ROE % Adjusted to Book Value is -20.24% as of Dec. 2025. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $154.42 (Possible Value Trap). The stock has 4 warning signs investors should review.

Onward Medical NV's ROE % for the quarter that ended in Dec. 2025 was -99.78%. Onward Medical NV's PB Ratio for the quarter that ended in Dec. 2025 was 4.93. Onward Medical NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -20.24%.

Onward Medical NV ROE % Adjusted to Book Value Related Terms

Onward Medical NV ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Onward Medical NV's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onward Medical NV ROE % Adjusted to Book Value Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -17.91 -20.13 -17.25

Onward Medical NV Semi-Annual Data
Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -22.23 -21.76 -19.63 -16.56 -20.24

ONWRF vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Onward Medical NV's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onward Medical NV ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's ROE % Adjusted to Book Value falls into.


ONWRF
37GF Score
Onward Medical NV ONWRF
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onward Medical NV ROE % Adjusted to Book Value Calculation

Onward Medical NV's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-85.03% / 4.93
=-17.25%

Onward Medical NV's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-99.78% / 4.93
=-20.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -20.24% mean?
Onward Medical NV (ONWRF) has a ROE % Adjusted to Book Value of -20.24% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Onward Medical NV and its competitors.
Is Onward Medical NV's ROE % Adjusted to Book Value too high?
Onward Medical NV's current ROE % Adjusted to Book Value is -20.24%. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's ROE % Adjusted to Book Value compare to VRTX and REGN?
Onward Medical NV's ROE % Adjusted to Book Value of -20.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Onward Medical NV and its competitors. Onward Medical NV's current ROE % Adjusted to Book Value is -20.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $154.42, compared to a current price of $2.96 — trading 98.1% below its estimated fair value. The current ROE % Adjusted to Book Value is -20.24%. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current ROE % Adjusted to Book Value is -20.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onward Medical NV (ONWRF) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of $2.96 is trading 98.1% below its estimated GF Value™ of $154.42. GuruFocus considers Onward Medical NV to be Possible Value Trap.

Key valuation signals for ONWRF:

  • ROE % Adjusted to Book Value: -20.24%
  • GF Value™: $154.42 vs. price of $2.96 (98.1% below fair value)
  • GF Score™: 37/100 with 4 warning signs

No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onward Medical NV Business Description

Other Exchanges 63E:GermanyONWD:Belgium
Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score

Get the complete analysis for ONWRF

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.96
Price
$154.42
GF Value